AbCellera Biologics Inc vs Elastic NV — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Elastic NV trades at $75.22 (market cap $7.94B). The key difference: Elastic NV is far larger — about 2.7× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Elastic NV nearer its low. Which is the better fit depends on your goals.
| ABCL | ESTC | |
|---|---|---|
Market Cap | $2.99B | $7.94B |
Sector | Health | Technology |
52-Week High | $9.76 | $94.47 |
52-Week Low | $2.78 | $43.30 |
Enterprise Value | $2.58B | $7.16B |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →